239 related articles for article (PubMed ID: 31990347)
1. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.
Vernerová L; Horváthová V; Kropáčková T; Vokurková M; Klein M; Tomčík M; Oreská S; Špiritović M; Štorkánová H; Heřmánková B; Kubínová K; Kryštůfková O; Mann H; Ukropec J; Ukropcová B; Vencovský J
Rheumatology (Oxford); 2020 Sep; 59(9):2491-2501. PubMed ID: 31990347
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle.
D'Orlando C; Marzetti E; François S; Lorenzi M; Conti V; di Stasio E; Rosa F; Brunelli S; Doglietto GB; Pacelli F; Bossola M
Muscle Nerve; 2014 Apr; 49(4):528-33. PubMed ID: 23835743
[TBL] [Abstract][Full Text] [Related]
3. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
4. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.
Smith IJ; Aversa Z; Alamdari N; Petkova V; Hasselgren PO
J Cell Biochem; 2010 Nov; 111(4):1059-73. PubMed ID: 20677217
[TBL] [Abstract][Full Text] [Related]
5. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
6. Effects of pre-exercise feeding on serum hormone concentrations and biomarkers of myostatin and ubiquitin proteasome pathway activity.
Dalbo VJ; Roberts MD; Hassell S; Kerksick CM
Eur J Nutr; 2013 Mar; 52(2):477-87. PubMed ID: 22476926
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
8. Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis.
Carrarelli P; Yen CF; Arcuri F; Funghi L; Tosti C; Wang TH; Huang JS; Petraglia F
Fertil Steril; 2015 Sep; 104(3):744-52.e1. PubMed ID: 26086422
[TBL] [Abstract][Full Text] [Related]
9. Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.
Lima AR; Martinez PF; Okoshi K; Guizoni DM; Zornoff LA; Campos DH; Oliveira SA; Bonomo C; Pai-Silva MD; Okoshi MP
Int J Exp Pathol; 2010 Feb; 91(1):54-62. PubMed ID: 20002838
[TBL] [Abstract][Full Text] [Related]
10. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
Mahoudeau A; Anquetil C; Tawara N; Khademian H; Amelin D; Bolko L; Silvestro M; Cin JD; Tendrel B; Tardif V; Mariampillai K; Butler-Browne G; Benveniste O; Allenbach Y
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12849. PubMed ID: 36168256
[TBL] [Abstract][Full Text] [Related]
11. Muscle myostatin signalling is enhanced in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bonetto A; Penna F; Reffo P; Bossola M; Bonelli G; Doglietto GB; Baccino FM; Rossi Fanelli F
Eur J Clin Invest; 2008 Jul; 38(7):531-8. PubMed ID: 18578694
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy and maximal eccentric exercise alters myostatin-related gene expression in postmenopausal women.
Dieli-Conwright CM; Spektor TM; Rice JC; Sattler FR; Schroeder ET
J Strength Cond Res; 2012 May; 26(5):1374-82. PubMed ID: 22395277
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle.
Han X; Møller LLV; De Groote E; Bojsen-Møller KN; Davey J; Henríquez-Olguin C; Li Z; Knudsen JR; Jensen TE; Madsbad S; Gregorevic P; Richter EA; Sylow L
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1241-1257. PubMed ID: 31402604
[TBL] [Abstract][Full Text] [Related]
15. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
[TBL] [Abstract][Full Text] [Related]
16. Short bouts of stretching increase myo-D, myostatin and atrogin-1 in rat soleus muscle.
Peviani SM; Gomes AR; Moreira RF; Moriscot AS; Salvini TF
Muscle Nerve; 2007 Mar; 35(3):363-70. PubMed ID: 17143883
[TBL] [Abstract][Full Text] [Related]
17. Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats.
Ramírez C; Russo TL; Sandoval MC; Dentillo AA; Couto MA; Durigan JL; Salvini TF
Am J Phys Med Rehabil; 2011 Nov; 90(11):930-9. PubMed ID: 21959222
[TBL] [Abstract][Full Text] [Related]
18. A potential indicator of denervated muscle atrophy: the ratio of myostatin to follistatin in peripheral blood.
Wu RH; Wang P; Yang L; Li Y; Liu Y; Liu M
Genet Mol Res; 2011 Oct; 10(4):3914-23. PubMed ID: 22033906
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.
Enoki Y; Watanabe H; Arake R; Sugimoto R; Imafuku T; Tominaga Y; Ishima Y; Kotani S; Nakajima M; Tanaka M; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
Sci Rep; 2016 Aug; 6():32084. PubMed ID: 27549031
[TBL] [Abstract][Full Text] [Related]
20. New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.
Pasteuning-Vuhman S; Boertje-van der Meulen JW; van Putten M; Overzier M; Ten Dijke P; Kiełbasa SM; Arindrarto W; Wolterbeek R; Lezhnina KV; Ozerov IV; Aliper AM; Hoogaars WM; Aartsma-Rus A; Loomans CJ
FASEB J; 2017 Jan; 31(1):238-255. PubMed ID: 27733450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
